United StatesBreaking News

IQSTEL (NASDAQ:IQST) reported $207 million in preliminary first-half net revenue to demonstrate its ongoing 59 percent year-over-year growth.

Greenwich LifeSciences (NASDAQ:GLSI) said European regulators approved combined HLA enrollment across approximately 170–180 FLAMINGO-01 clinical sites.

Medicus Pharma (NASDAQ:MDCX) received central IRB approval and written FDA feedback for its optimized Phase 2 ANT-2111-02 clinical study.

The US struck an oil tanker near Iran's main export terminal for the first time since the restart of the blockade on the Islamic Republic's ports as Washington intensifies strikes against Tehran. Tyler Kendall reports on Bloomberg Television.

Gibraltar Industries (NASDAQ:ROCK) completed a two-step divestiture of its Renewables business by selling its racking and foundations operations to Unirac.

Abbott (NYSE:ABT) reported second-quarter 2026 sales of $12.6 billion and an adjusted earnings of $1.31 per diluted share.

ManpowerGroup (NYSE:MAN) reported second-quarter 2026 revenues of $4.9 billion and net earnings of $53.5 million.

LCNB Corp. (NASDAQ:LCNB) reported a record second-quarter net income of $7.5 million and earnings of $0.53 per share for the three months ended June 30.

Moderna (NASDAQ:MRNA) dosed the first U.S. participant in its Phase 1 trial evaluating the mRNA-4200 cancer antigen therapy.

Main Street Capital (NYSE:MAIN) projected second-quarter distributable net investment income between $1.02 and $1.06 per share.

Horizon Aircraft (NASDAQ:HOVR) reported fiscal 2026 fourth-quarter results, highlighting a strengthened cash balance of $78.3 million.

Merck (NYSE:MRK) received FDA approval for Lipfendra 20 mg after a Phase 3 trial showed a 56% LDL-C reduction versus placebo.